# Northrim Bancorp Inc: overview

NRIM · Nasdaq · CIK 1163370 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nrim.md) · [Financials](/companies/nrim/financials.md) · [Filings](/companies/nrim/filings.md) · [Insiders](/companies/nrim/insiders.md)

Latest reported revenue: [$63.9m](/filings/0001163370-26-000029.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Jul 31, 2026 (XBRL us-gaap:Revenues, accession 0001163370-26-000029).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [51.0](/filings/0001163370-25-000043.md) | [54.8 d](/filings/0001163370-26-000007.md) | [54.6](/filings/0001163370-26-000021.md) | [61.4](/filings/0001163370-26-000029.md) | [77.2](/filings/0001163370-25-000043.md) | [62.3 d](/filings/0001163370-26-000007.md) | [59.8](/filings/0001163370-26-000021.md) | [63.9](/filings/0001163370-26-000029.md) |
| Gross margin | % | [75.2%](/filings/0001163370-25-000043.md) | [77.8% d](/filings/0001163370-26-000007.md) | [83.8%](/filings/0001163370-26-000021.md) | [78.5%](/filings/0001163370-26-000029.md) | [84.0%](/filings/0001163370-25-000043.md) | [80.3% d](/filings/0001163370-26-000007.md) | [81.3%](/filings/0001163370-26-000021.md) | [81.8%](/filings/0001163370-26-000029.md) |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [17.3%](/filings/0001163370-25-000043.md) | [19.9% d](/filings/0001163370-25-000043.md) | [24.4%](/filings/0001163370-26-000029.md) | [19.2%](/filings/0001163370-26-000029.md) | [35.1%](/filings/0001163370-26-000029.md) | [20.0% d](/filings/0001163370-26-000029.md) | [22.9%](/filings/0001163370-26-000029.md) | [24.0%](/filings/0001163370-26-000029.md) |
| Diluted EPS | $ per share | [0.39](/filings/0001163370-25-000043.md) | not reported | [0.60](/filings/0001163370-26-000021.md) | [0.52](/filings/0001163370-26-000029.md) | [1.20](/filings/0001163370-25-000043.md) | not reported | [0.61](/filings/0001163370-26-000021.md) | [0.68](/filings/0001163370-26-000029.md) |
| Free cash flow | $m | [(0.3) d](/filings/0001163370-25-000043.md) | [34.1 d](/filings/0001163370-26-000007.md) | [16.3](/filings/0001163370-26-000021.md) | [(4.7) d](/filings/0001163370-26-000029.md) | [89.9 d](/filings/0001163370-25-000043.md) | [32.3 d](/filings/0001163370-26-000007.md) | [24.3](/filings/0001163370-26-000021.md) | [39.5 d](/filings/0001163370-26-000029.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | [134](/filings/0001163370-25-000007.md) | [158](/filings/0001163370-26-000007.md) | [196](/filings/0001163370-26-000007.md) | [256](/filings/0001163370-26-000007.md) |
| Gross margin | % | not reported | [94.7%](/filings/0001163370-25-000007.md) | [79.4%](/filings/0001163370-26-000007.md) | [77.5%](/filings/0001163370-26-000007.md) | [81.7%](/filings/0001163370-26-000007.md) |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | [22.9%](/filings/0001163370-25-000007.md) | [16.0%](/filings/0001163370-26-000007.md) | [18.9%](/filings/0001163370-26-000007.md) | [25.3%](/filings/0001163370-26-000007.md) |
| Diluted EPS | $ per share | [6.00](/filings/0001163370-24-000010.md) | [5.27](/filings/0001163370-25-000007.md) | [1.12](/filings/0001163370-26-000007.md) | [1.66](/filings/0001163370-26-000007.md) | [2.87](/filings/0001163370-26-000007.md) |
| Free cash flow | $m | [110](/filings/0001163370-24-000010.md) | [74.3](/filings/0001163370-25-000007.md) | [32.6](/filings/0001163370-26-000007.md) | [(9.3)](/filings/0001163370-26-000007.md) | [134](/filings/0001163370-26-000007.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/nrim/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $81.2m | 2,926,599 |  | Added +160,879 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $33.6m | 1,210,516 |  | Added +3,908 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $26.3m | 948,559 |  | Reduced −15,395 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $23.8m | 857,671 |  | Added +84,605 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $22.6m | 815,361 |  | Added +66,645 |
| [MANUFACTURERS LIFE INSURANCE COMPANY, THE](/funds/928047.md) | 2026-06-30 | $21.9m | 789,126 |  | Reduced −4,896 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $18.6m | 668,901 |  | Reduced −70,917 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $15.6m | 562,928 |  | Added +55,896 |
| [De Lisle Partners LLP](/funds/2011184.md) | 2026-06-30 | $13.2m | 476,019 |  | Added +1,639 |
| [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $9.8m | 352,024 |  | Added +35,679 |

## Recent filings

[All 868 filings](/companies/nrim/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 16:46 ET | [10-Q](/filings/0001163370-26-000036.md) | Quarterly report, period 2026-09-30 | 0001163370-26-000036 |
| 2026-10-22 | 15:25 ET | [8-K](/filings/0001163370-26-000034.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001163370-26-000034 |
| 2026-10-15 | 17:28 ET | [8-K](/filings/0001163370-26-000032.md) | 2.02 Results of operations; 2.06 Material impairments; 8.01 Other events; 9.01 Financial statements and exhibits | 0001163370-26-000032 |
| 2026-07-31 | 14:14 ET | [10-Q](/filings/0001163370-26-000029.md) | Quarterly report, period 2026-06-30 | 0001163370-26-000029 |
| 2026-07-23 | 08:35 ET | [8-K](/filings/0001163370-26-000027.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001163370-26-000027 |
| 2026-07-23 | 20:08 ET | [8-K](/filings/0001163370-26-000025.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001163370-26-000025 |
| 2026-06-01 | 08:52 ET | [8-K](/filings/0001163370-26-000023.md) | 5.07 Shareholder vote results | 0001163370-26-000023 |
| 2026-05-01 | 14:06 ET | [10-Q](/filings/0001163370-26-000021.md) | Quarterly report, period 2026-03-31 | 0001163370-26-000021 |
| 2026-04-22 | 16:40 ET | [8-K](/filings/0001163370-26-000018.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001163370-26-000018 |
| 2026-04-14 | 12:33 ET | [DEF 14A](/filings/0001163370-26-000012.md) | Proxy statement, period 2025-12-31 | 0001163370-26-000012 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001163370-26-000007.md), filed Mar 6, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1163370
- Tickers: NRIM
- Exchange: Nasdaq
- SIC code: 6035 Savings Institution, Federally Chartered
- State of incorporation: AK
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 16:57 ET. No prices; not investment advice.